![Andrew May](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Andrew May is a Director at Intellia Therapeutics, Inc. and Chief Scientific Officer at Caribou Biosciences, Inc. He is on the Board of Directors at Intellia Therapeutics, Inc.
He received his undergraduate degree from the University of Oxford and a doctorate degree from the University of Oxford.
| Companies | Position | End |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
| INTELLIA THERAPEUTICS, INC. | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
